Vimseltinib Interactions
There are 136 drugs known to interact with vimseltinib, along with 2 disease interactions. Of the total drug interactions, 15 are major, 115 are moderate, and 6 are minor.
- View vimseltinib disease interactions (2)
Medications known to interact with vimseltinib
Note: Showing generic names only.
- afatinib
- aliskiren
- alpelisib
- ambrisentan
- apixaban
- artesunate
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- atorvastatin
- dabigatran
- daclizumab
- dalfampridine
- darolutamide
- daunorubicin
- daunorubicin liposomal
- dextromethorphan
- digoxin
- docetaxel
- dofetilide
- doxorubicin
- doxorubicin liposomal
- edoxaban
- efavirenz
- elagolix
- enfortumab vedotin
- epirubicin
- erlotinib
- erythromycin
- etoposide
- etranacogene dezaparvovec
- everolimus
- idarubicin
- idelalisib
- imatinib
- indacaterol
- interferon beta-1a
- interferon beta-1b
- irinotecan
- isoniazid
- lapatinib
- larotrectinib
- leflunomide
- lemborexant
- levoketoconazole
- lomitapide
- loperamide
- lurasidone
- lusutrombopag
- paclitaxel
- paclitaxel protein-bound
- pazopanib
- pegaspargase
- peginterferon beta-1a
- pexidartinib
- pitavastatin
- posaconazole
- pralsetinib
- prazosin
- procainamide
- ranolazine
- relugolix
- remdesivir
- repotrectinib
- rifampin
- rifaximin
- rimegepant
- riociguat
- ripretinib
- ritonavir
- rivaroxaban
- romidepsin
- rosuvastatin
- tacrolimus
- talazoparib
- tenofovir alafenamide
- tenofovir disoproxil
- terfenadine
- teriflunomide
- thioguanine
- tipranavir
- tolvaptan
- topotecan
- trabectedin
Vimseltinib disease interactions
There are 2 disease interactions with vimseltinib which include:
Report options
More about vimseltinib
- vimseltinib consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Romvimza
Romvimza is used to treat symptomatic tenosynovial giant cell tumor (TGCT) in adults when surgery ...
Turalio
Turalio (pexidartinib) is a kinase inhibitor for the treatment of tenosynovial giant cell tumor ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Abecma
Abecma is a CAR T cell therapy used to treat relapsed refractory multiple myeloma (RRMM); it is a ...
Accutane
Accutane (isotretinoin) is a form of vitamin A and is used to treat severe nodular acne. Includes ...
Adstiladrin
Adstiladrin (nadofaragene firadenovec-vncg) is a gene therapy used to treat high-risk Bacillus ...
Amnesteem
Amnesteem is used for acne, acute nonlymphocytic leukemia, granuloma annulare, rosacea
Amtagvi
Amtagvi (lifileucel) is a type of medicine called “tumor-derived autologous T cell immunotherapy” th ...
Anktiva
Anktiva (N-803) is used to treat specific types of bladder cancer. It is FDA-approved to be used ...
Pexidartinib
Pexidartinib systemic is used for tenosynovial giant cell tumor
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.